Engineering / Physics
| Speaker |
Titles |
| Wust (D) |
Standards for non-invasive control, planning and performance of regional hyperthermia |
| Van Rhoon (NL) |
Innovation in Devices and Technology for Hyperthermia |
| Ter Haar (NL) |
High intensity focused ultrasound |
| Lagendijk (NL) |
The potential use of a 3T MRI for regional hyperthermia |
| Kuster (CH) |
Easy-to-use, real-time & reliable hyperthermia treatment planning: expectations & reality |
| Diederich (USA) |
3D-Control of thermal therapy with catheter-based ultrasound |
| Das (USA) |
Fast optimization and control in electromagnetic thermal therapy using reduced order techniques |
| McDannold (USA) |
MRI-guided focused ultrasound for thermal ablation and drug delivery |
| Cendes (USA) |
Advances in computer modeling for thermal therapy and other medical applications |
| Kato (J) |
Focused deep heating with annular-shaped inductive aperture-type applicator |
| Kuroda (J) |
Target-tracking thermometry for focused ultrasound therapy of liver based on filtered venography and self-reference techniques |
| Ito (J) |
Microwave Interstitial and Intracavitary Hyperthermia |
Clinic
| Speaker |
Tentative Titles |
| Jordan (D) |
Thermotherapy using magnetic nanoparticles: Principles and clinical application |
| Franckena (NL) |
Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: An update of the Dutch Deep Hyperthermia Trial |
| Jones (USA) |
An update of the Duke experience for thermally sensitive (TS) liposomes containing doxorubicin (ThermodoxTM;TDox) Iin combination with hyperthermia (HT) in breast cancer patients with chest wall (CW) recurrence |
| Colombo (I) |
Chemio-Hyperthermia for treatment of non-muscle invasive bladder cancer. An overview on basic science and clinical outcomes.' |
| Eggermont (NL) |
TNF-isolated limb perfusion program for extremity soft tissue sarcomas |
| Maluta (I) |
Impact of hyperthermia combined with radiochemotherapy in locally advanced pancreatic cancer |
| Tschoep (D) |
Gemcitabine (GEM) + cisplatin (CIS) combined with regional hyperthermia (RHT) in patients with GEM-pre-treated pancreatic cancer: Results of the ESHO phase II trial |
| Lindner (D) |
Heat inducible cytotoxicity of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes |
| Hurwitz (USA) |
Hyperthermia for prostate cancer: Clinical results and future directions |
| Myerson (USA) |
Thermal dosimetry revisited |
| Kiel (USA) |
Hyperthermia and radiation therapy, with and without chemotherapy, for locally advanced or recurrent breast carcinoma |
| Huilgol (IND) |
Clinical hyperthermia: Opportunities and challenges in developing countries. |
| Issels (D) |
Risk of early progression in patients with high-risk soft tissue sarcomas: results of the phase III randomized prospective trial of neoadjuvant chemotherapy with or without regional hyperthermia (EORTC-ESHO Intergroup trial) |
| Sakurai (J) |
Clinical studies using Thermotron-RF8 for advanced lung, esophageal and rectal cancer -Gunma University experience- |
| Shao (PR China) |
Intracavitary hyperthermia combined with radiotherapy for the treatment of patients with stage Ib2 cervical cancer |
| Tanaka (J) |
The past and present status of hyperthermic oncology in Japan |
| Zhang (PR China) |
Clinical study of recombinant human p53 adenovirus combined with hyperthermia in advanced cancer ( a report of 32 cases ) |
| Wessalowski (D) |
Clinical hyperthermia: Opportunities and challenges in developing countries. |
Biology
| Speaker |
Tentative Titles |
| Vaupel (G) |
Impact of tumor hypoxia on the efficacy of hyperthermia: Help or hindrance? |
| Horsman (DK) |
Vascular based approaches |
| Calderwood (USA) |
Role of scavenger receptors in Hsp70-based immunotherapy |
| Asea (USA) |
HSP25 Silencing |
| Repasky (USA) |
Complex effects of hyperthermia on the immune system and implications for cancer therapy |
| Van Eden (NL) |
Heat shock proteins induce T-cell regulation of chronic inflammation |
| Di Nicola (I) |
Vaccination of indolent non Hodgkin's lymphoma patients with autologous dendritic cells loaded with heat shocked and killed autologous tumor cells: a phase II study. |
| Dewhirst (USA) |
Role of HIF-1 in response of tumor to hyperthermia |
| Evans (USA) |
Thermal targeting of vascular endothelial gateways to tumors |
| Khleif (USA) |
Cancer vaccine, a promises or a reality |
| Kondo (J) |
Genes and genetic networks responsive to mild hyperthermia in human leukemia U937 cells |
| Multhoff (D) |
Hsp70 and HLA-E serve as activatory and inhibitory ligands for CD94 positive NK cells |
| Ohtsuka (J) |
Molecular chaperone activity of Hsp70 and Hsp40, and its medical application |
| Takahashi (J) |
The study of target genes deciding heat-sensitivity |
| Ohnishi (J) |
Localization of DSB-recognizing proteins in the nucleus after heat treatment |
Program committee
| ESHO |
Issels, Munich; Gerard Van Rhoon, Rotterdam and Valeria Milani, Munich |
| STM |
Mark Hurwitz, Boston (MA); Paul Stauffer, Durham (NC); Robert Griffin, Little Rock (AK); Dieter Haemmerich, Charleston (SC) |
| ASHO |
Takeo Onishi, Nara, Japan; Koichi Ito, Japan; Nagraj Huilgol, Mumbai, India |
Important Note:
Preeminent speakers from the Asian Society of Hyperthermic Oncology will be named at a later date. The final Program and Abstract Book will be distributed onsite to registrants at the meeting.
